← All diseases Cancer

Melanoma (metastatic)

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchStrongest evidence only (28)Meta-analysis (4)Treatment guideline (2)Systematic review (8)Phase 3 study (8)Randomized trial (6)Clinical Research (581)Review article (181)Early Study (Phase 1 or 2) (58)Description of some patients (244)Laboratory or animal study (45)Commentary or editorial (17)Retracted publication (2) Studies currently seeking participants only (43)

Filter

Publications and studies (1870)

• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Dabrafenib plus trametinib for compassionate use in metastatic melanoma: A STROBE-compliant retrospective observational postauthorization study. (2017/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Brain metastasis in a patient with melanoma receiving Pembrolizumab therapy: A case report and review of the literature. (2017/12/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Primary adrenal malignant melanoma: A case report and review of literature. (2017/12/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Acute liver failure caused by pembrolizumab in a patient with pulmonary metastatic liver cancer: A case report. (2017/12/01) ♡
• Effect of Enzymatic pre-treatment of microalgae extracts on their anti-tumor activity. (2017/12/01) ♡
• Ruthenium brachytherapy for uveal melanoma - single institution experience. (2017/12/01) ♡
• Durvalumab for the treatment of urothelial carcinoma. (2017/12/01) ♡
• Metastatic lymphadenomegaly in dogs - cytological study. (2017/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Anti-PD-1 and PD-L1 antibodies in metastatic melanoma. (2017/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Management of the cutaneous adverse effects of antimelanoma therapy. (2017/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. An update on the relevance of vaccine research for the treatment of metastatic melanoma. (2017/12/01) ♡
• Greater distance to an academic medical center is associated with poorer melanoma prognostic factors: The University of Colorado Experience. (2017/11/15) ♡
• Serum exosomes as predictors of clinical response to ipilimumab in metastatic melanoma. (2017/11/06) ♡
• Impaired NK cell recognition of vemurafenib-treated melanoma cells is overcome by simultaneous application of histone deacetylase inhibitors. (2017/11/06) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A Case of Immune Thrombocytopenia as a Rare Side Effect of an Immunotherapy with PD1-Blocking Agents for Metastatic Melanoma. (2017/11/01) ♡
• Acute Angle Closure Precipitated by Hemorrhage and Necrosis of a Large Uveal Melanoma in the Setting of Systemic Immunomodulatory Therapy. (2017/11/01) ♡
• Choroidal Melanoma Mimicker: A Case of Metastatic Clear-Cell Renal Cell Carcinoma. (2017/11/01) ♡
• RAGE-aptamer Attenuates the Growth and Liver Metastasis of Malignant Melanoma in Nude Mice. (2017/11/01) ♡
• A novel immunization strategy using cytokine/chemokines induces new effective systemic immune responses, and frequent complete regressions of human metastatic melanoma. (2017/10/30) ♡
• Systemic administration of β-glucan of 200 kDa modulates melanoma microenvironment and suppresses metastatic cancer. (2017/10/30) ♡
• Connexin 43 upregulation by dioscin inhibits melanoma progression via suppressing malignancy and inducing M1 polarization. (2017/10/15) ♡
• Melaleuca quinquenervia essential oil inhibits α-melanocyte-stimulating hormone-induced melanin production and oxidative stress in B16 melanoma cells. (2017/10/15) ♡
• Painful subcutaneous lesions in a patient with metastatic melanoma: a case of lymphocytic panniculitis associated with vemurafenib. (2017/10/15) ♡
• Chronic lymphocytic leukaemia and secondary skin malignancies. (2017/10/12) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [Post-traumatic scleromalacia]. (2017/10/06) ♡
• SIRT1 regulates Mxd1 during malignant melanoma progression. (2017/10/03) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Balloon cell melanoma metastasis to the temporal lobe. (2017/10/01) ♡
• Metastatic anorectal melanomas - An exploratory retrospective analysis on the benefits of systemic therapy versus best supportive care in a resource-limited setting from India. (2017/10/01) ♡
• Oncogenic BRAF mutations and p16 expression in melanocytic nevi and melanoma in the Polish population. (2017/10/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Acute polyneuropathy in a metastatic melanoma patient treated with vemurafenib and cobimetinib. (2017/10/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Cardiac Metastases from Malignant Melanoma: The "Charcoal Heart". (2017/10/01) ♡
• Role of radiotherapy in extracranial metastatic malignant melanoma in the modern era. (2017/09/30) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Ipilimumab-induced Adenohypophysitis and Orbital Apex Syndrome: Importance of Early Diagnosis and Management. (2017/09/20) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Erythema multiforme major in a patient with metastatic melanoma treated with nivolumab. (2017/09/15) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Metastatic Melanoma of the Optic Nerve Sheath. (2017/09/14) ♡
• An agent for optical imaging of TrkC-expressing, breast cancer. (2017/09/14) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Cutaneous metastases as initial presentation of malignancy. (2017/09/13) ♡
• Retracted publicationiThis research has been withdrawn by science itself, for example due to a flaw in the method or unreliable data. Do not use it as support and do not discuss it as evidence. Liver X receptors constrain tumor development and metastasis dissemination in PTEN-deficient prostate cancer. (2017/09/05) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. PET Scan Misses Cutaneous Melanoma Metastasis with Significant Tumour Size and Tumour Thickness. (2017/09/02) ♡
• Defect Reconstruction of the Nose After Surgery for Nonmelanoma Skin Cancer: Our Clinical Experience. (2017/09/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Severe Allograft Rejection and Autoimmune Hemolytic Anemia After Anti-PD1 Therapy in a Kidney Transplanted Patient. (2017/09/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Utility of ipilimumab in melanoma patients who progress on anti-PD-1 therapy. (2017/09/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Anti-PD-1 monotherapy versus anti-PD1 plus anti-CTLA4 in advanced melanoma: how do we decide? (2017/09/01) ♡
• Phase 3 studyiResearch in a large group of patients, the final step before a treatment can be approved. What comes out here carries significant weight. Vitamin D supplementation in cutaneous malignant melanoma outcome (ViDMe): a randomized controlled trial. (2017/08/23) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A case of de novo palmoplantar psoriasis with psoriatic arthritis and autoimmune hypothyroidism after receiving nivolumab therapy. (2017/08/15) ♡
• Abl kinase regulation by BRAF/ERK and cooperation with Akt in melanoma. (2017/08/10) ♡
• Commensal microbiota maintains alveolar macrophages with a low level of CCL24 production to generate anti-metastatic tumor activity. (2017/08/07) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The HGF/SF Mouse Model of UV-Induced Melanoma as an In Vivo Sensor for Metastasis-Regulating Gene. (2017/07/28) ♡
• BRAF(V600) inhibition alters the microRNA cargo in the vesicular secretome of malignant melanoma cells. (2017/07/18) ♡
• Metastatic melanoma presenting as malignant biliary obstruction of the common bile duct demonstrated with single-operator digital cholangioscopy. (2017/07/14) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.